Lupin

Lupin gains USFDA approval for Loteprednol Etabonate Ophthalmic Gel

Read more

Lupin receives approval from US FDA for Prucalopride Tablets

Read more

Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual Meeting 2025

Read more

Lupin and SteinCares enter into License and Supply Agreement for Ranibizumab in Latin America

Read more

Lupin collaborates with Honeywell, plans for HFO technology in Inhalers

Read more

Punita Lal joins Lupin board as Additional Director

Read more

Lupin gains USFDA approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg

Read more

Lupin launches Tolvaptan Tablets in the US

Read more

We are well-aligned to capitalise on the CDMO opportunity

Read more

Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg

Read more